Search research articles
Contact Us
Filters
Showing results (431-440 of 481) with videos related to
Page
of 49
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2009
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma
Richard L Piekarz, Robin Frye, Maria Turner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 2009
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
Shivaani Kummar, Martin E Gutierrez, Erin R Gardner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2011
Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancer
Nancy M Hardy, Miriam E Mossoba, Seth M Steinberg, et al.
Neuro-Oncology
|
April 25, 2022
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity
Andrea M Gross, Brittany Glassberg, Pamela L Wolters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
Srivandana Akshintala, R Taylor Sundby, Donna Bernstein, et al.
Leukemia & Lymphoma
|
October 1, 2016
Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone
Elisabet E Manasanch, Carlos Fernández de Larrea, Adriana Zingone, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2019
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy
Raffit Hassan, Betsy Morrow, Anish Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2017
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors
Anish Thomas, Christophe E Redon, Linda Sciuto, et al.
Blood Advances
|
February 5, 2025
Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation
Mustafa A Hyder, Dimana Dimitrova, Ruby Sabina, et al.
Science Translational Medicine
|
January 28, 2021
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies
Camille Tlemsani, Nobuyuki Takahashi, Lorinc Pongor, et al.
Page
of 49
Search research articles
Search
Showing results (431-440 of 481) with videos related to
Sort By:
Page
of 49
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2009
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma
Richard L Piekarz, Robin Frye, Maria Turner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 2009
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
Shivaani Kummar, Martin E Gutierrez, Erin R Gardner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2011
Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancer
Nancy M Hardy, Miriam E Mossoba, Seth M Steinberg, et al.
Neuro-Oncology
|
April 25, 2022
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity
Andrea M Gross, Brittany Glassberg, Pamela L Wolters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
Srivandana Akshintala, R Taylor Sundby, Donna Bernstein, et al.
Leukemia & Lymphoma
|
October 1, 2016
Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone
Elisabet E Manasanch, Carlos Fernández de Larrea, Adriana Zingone, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2019
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy
Raffit Hassan, Betsy Morrow, Anish Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2017
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors
Anish Thomas, Christophe E Redon, Linda Sciuto, et al.
Blood Advances
|
February 5, 2025
Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation
Mustafa A Hyder, Dimana Dimitrova, Ruby Sabina, et al.
Science Translational Medicine
|
January 28, 2021
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies
Camille Tlemsani, Nobuyuki Takahashi, Lorinc Pongor, et al.
Page
of 49